Cargando…

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2

The successive emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has presented a major challenge in the management of the coronavirus disease (COVID-19) pandemic. There are growing concerns regarding the emerging variants escaping vaccines or therapeutic neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyakawa, Kei, Jeremiah, Sundararaj Stanleyraj, Yamaoka, Yutaro, Koyama, Takahiko, Tokumasu, Reitaro, Kudo, Michiharu, Kato, Hideaki, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866700/ https://www.ncbi.nlm.nih.gov/pubmed/35223905 http://dx.doi.org/10.3389/fmed.2022.811004

Ejemplares similares

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
por: Yamaoka, Yutaro, et al.
Publicado: (2022)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2022)

Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2
por: Ino, Yoko, et al.
Publicado: (2022)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games
por: Koyama, Takahiko, et al.
Publicado: (2022)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy
por: Hatayama, Yasuyoshi, et al.
Publicado: (2022)

Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor
por: Funabashi, Rikako, et al.
Publicado: (2021)

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors
por: Goto, Atsushi, et al.
Publicado: (2021)

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
por: Kato, Hideaki, et al.
Publicado: (2022)

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
por: Kato, Hideaki, et al.
Publicado: (2022)

Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
por: Goto, Atsushi, et al.
Publicado: (2023)

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests
por: Yamaoka, Yutaro, et al.
Publicado: (2021)

Prospective Clinical Evaluation of the Diagnostic Accuracy of a Highly Sensitive Rapid Antigen Test Using Silver Amplification Technology for Emerging SARS-CoV-2 Variants
por: Obata, Kazuaki, et al.
Publicado: (2022)

Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
por: Goto, Keiko, et al.
Publicado: (2020)

Role of claudin species–specific dynamics in reconstitution and remodeling of the zonula occludens
por: Yamazaki, Yuji, et al.
Publicado: (2011)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
por: Nakai, Yusuke, et al.
Publicado: (2022)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Evaluating Clinical Genome Sequence Analysis by Watson for Genomics
por: Itahashi, Kota, et al.
Publicado: (2018)

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
por: Miyakawa, Kei, et al.
Publicado: (2022)

BCA2/Rabring7 Promotes Tetherin-Dependent HIV-1 Restriction
por: Miyakawa, Kei, et al.
Publicado: (2009)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein
por: Kimura, Yayoi, et al.
Publicado: (2022)

A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron
por: Maeda, Ryota, et al.
Publicado: (2022)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Evaluation of a combination protocol of CT-first triage and active telemedicine methods by a selected team tackling COVID-19: An experimental research study
por: Miyake, Shigeta, et al.
Publicado: (2021)

Rapid multiplex microfiber-based immunoassay for anti-MERS-CoV antibody detection
por: Hoy, Carlton F.O., et al.
Publicado: (2019)

Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice
por: Nagata, Kayoko, et al.
Publicado: (2022)

Pathophysiology and epidemiology of virus-induced asthma
por: Kimura, Hirokazu, et al.
Publicado: (2014)

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
por: Kimura, Yayoi, et al.
Publicado: (2021)

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment
por: Koyama, Takahiko, et al.
Publicado: (2020)

Hepatitis A Virus Vaccine Escape Variants and Potential New Serotype Emergence
por: Pérez-Sautu, Unai, et al.
Publicado: (2011)

Deletion of Tricellulin Causes Progressive Hearing Loss Associated with Degeneration of Cochlear Hair Cells
por: Kamitani, Toru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_62o2h09clnllmpm6gk3g32b2hp